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Contemporary Management of 
Aortic Dissection
Eli Cehelyk, Taylor Haddad, Dr. Babak Abai*
Introduction
• Background
– Aortic dissection - tear in the intima of the aortic wall, creating a 
false lumen between the intima and adventitia.
– Mortality rate of up to 50% within 48 hours if left untreated
– Worse outcomes with concomitant organ malperfusion
– Thoracic Endovascular Aortic Repair (TEVAR)





– Increasing popularity of TEVAR
– Deadly disease pathology
– Best medical therapy vs. intervention
– Uncertain outcomes
• Gap 
– Optimal treatment of aortic dissection I and III




– How do clinical outcomes vary between patients with 
descending aortic dissections, with and without 
concurrent organ malperfusion, who were managed with 
thoracic endovascular aortic repair (TEVAR) or best 
medical therapy (BMT)?
• Hypothesis
– Clinical outcomes are significantly worse in patients with 
descending aortic dissections who necessitated 
additional branch stenting due to concomitant organ 




– Medical chart review
• Population / study sample
– Descending aortic dissection patients (excl type II)
– 11 (TEVAR alone), 11 (TEVAR + branch), 16 (BMT)
• Intervention 
– None
• Data source and collection
– Vascular surgery database, medical charts
• Rationale for Approach




– ANOVA + post-hoc
– T-Test
– Hierarchical Linear Regression
Results
• Order of results: TEVAR alone, TEVAR+, BMT
• 0 deaths
• Length of stay (p=0.005)
– 7 days, 21 days, 12 days
• Age at presentation (p=0.007)
– 70, 51, 62
• Age inversely predicted length of stay (p=0.008)
– Younger patients required longer hospitalization
Results
• Systolic blood pressures at presentation 
(p=0.025)
– 168, 201, 167
• Diagnosis of concomitant organ 
malperfusion correlated with a longer length 
of stay (p=0.008)
• Need for readmission
– 1/11, 1/11, 8/16
• 3 requiring TEVAR
Conclusions
• Summary
– Additional branch stenting due to malperfusion
• younger, higher systolic blood pressures, longer hospital stays
– Medically managed patients required more hospitalizations 
and TEVAR
• How do your findings fit with current literature?
– Trend towards prophylactic TEVAR for patients normally 
managed with BMT
– Age + dissection not explored
• Implications + Clinical Impacts
– Higher risk group?
• What should be done?
– Prophylactic TEVAR for BMT patients?
Future Directions
• Replicate with a larger sample size
• TEVAR for medically managed
• Explore age and outcomes related to 
dissection
–Why do younger patients have worse tears?
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